- Filed
- May 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 2, 2024 | 5.97M sh |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $102.15M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $102M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $114.85M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $115.05M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $71.43M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $83.47M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $92.93M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $107.03M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $1.48M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $2.38M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $62.72M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $39.22M |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 5.62M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $527K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$24.13M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $106.03M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $125.32M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$1.87 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$1.87 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $4.17M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $5.26M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$10.54M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$10.88M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | −$445K |
| Revenue | Q1 2024 · Mar 31, 2023 | $866K |